Publicaciones

...less

1. Adán-Castro E, Zamora M, Granados-Carrasco D, Siqueiros-Márquez L, Garía-Rodrigo JF, Bertsch T, Triebel J, Martínez de la Escalera G, Robles JP, Clapp C. , Topical ophthalmic administration of VIAN-c4551 antiangiogenic peptide for diabetic macular edema: Preclinical efficacy and ocular pharmacoxinetics. , BioRxiv, November 2024

2. Adán-Castro E, Zamora M, Granados-Carrasco D, Siqueiros-Márquez L, Garía-Rodrigo JF, Bertsch T, Triebel J, Martínez de la Escalera G, Robles JP, Clapp C. , Topical ophthalmic administration of VIAN-c4551 antiangiogenic peptide for diabetic macular edema: Preclinical efficacy and ocular pharmacoxinetics. , BioRxiv, November 2024

3. Macías F, Ulloa M, Clapp C, Martínez de la Escalera G, Arnold E. , Prolactin protects hippocampal neurons against H2O2-induced neurotoxicity by suppressing BAX and NOX4 via the NF-κB signaling pathway. , Plos One, November 2024; 19(11), e0313328

4. Robles JP, Zamora M, Garcia-Rodrigo JF, Perez AL, Bertsch T, Martínez de la Escalera G, Triebel J, Clapp C. , The apoptotic, inflammatory, and fibrinolytic actions of vasoinhibin are in a motif different from its antiangiogenic HGR motif. , Endocrinology, November 2024; 165, 1-12

5. Robles JP, Zamora M, Garcia-Rodrigo JF, Perez AL, Bertsch T, Martínez de la Escalera G, Triebel J, Clapp C. , The apoptotic, inflammatory, and fibrinolytic actions of vasoinhibin are in a motif different from its antiangiogenic HGR motif. , Endocrinology, November 2024; 165, 1-12

6. Castillo X, Ortíz G, Arnold E, Wu Z, Tovar y Romo LB, Clapp C, Martínez de la Escalera G. , The influence of the prolactin/vasoinhibin axis on post-stroke lesion volume, astrogliosis, and survival. Journal of , Journal Of Neuroendocrinology, July 2024; 2024, e13415

7. Ulloa M, Macías F, Clapp C, Martínez de la Escalera G, Arnold E. , Prolactin is an endogenous antioxidant factor in astrocytes that limits oxidative stress-induced astrocytic cell death via the STAT3/NRF2 signaling pathway., Neurochemical Research, May 2024; 49, 1879-1901

8. Vázquez-Carrillo DI, Ocampo-Ruíz AL, Báez-Mesa A, Ramírez-Hernández G, Adán-Castro E, García-Rodrigo JF, Dena-Beltrán JL, de los Ríos EA, Sánchez-Martínez MK, Ortíz-Arballo MG, Martínez de la Escalera G, Clapp C, Macotela Y. , Dopamine D2 receptor antagonist counteracts hyperglycemia and insulin resistance in diet-induced obese male mice, Plos One, April 2024; 19, e0301496

9. Núñez-Amaro CD, López M, Adán-Castro E, Robles-Osorio ML, García-Franco L, García-Roa M, Villalpando-Robles Y, Ramírez-Neria P, Pineiro N, Rubio-Mijangos JF, Sánchez J, Ramírez-Hernández G, Siqueiros-Márquez L, Díaz-Lezama N, López-Star E, Bertsch T, Martínez de la Escalera G, Triebel J, Clapp C. , Levosulpiride for the treatment of diabetic macular oedema: A phase 2 randomized clinical trial. , EYE, February 2024; 38, 520-528

10. Luzardo-Ocampo I, Ocampo-Ruíz AL, Dena-Beltrán JL, Martínez de la Escalera G, Clapp C, Macotela Y. , The diversity of gut microbiota at weaning is altered in prolactin receptor null mice. , Nutrients, November 2023; 15, 3447

11. Ulloa M, Macías F, Martínez de la Escalera G, Arnold E. , Acciones del H2O2 como señalizador redox y como agente de estrés oxidante en la diabetes mellitus, Tip Revista Especializada en Ciencias Quimico-Biológicas, November 2023; 26, 1-10

12. García-Rodrigo JF, Ortíz-Arballo G, Martínez-Díaz OF, Furuzawa-Carballeda J, Ruíz-Herrera X, Macías F, Ledesma-Colunga MG, Martínez de la Escalera G, Clapp C. , Prolactin inhibits or stimulates the inflammatory response of joint tissues in a cytokine-dependent manner. , Endocrinology, October 2023; bqad156, 1-14 online

13. Luzardo-Ocampo, I., Dena-Beltrán, J. L., Ruíz-Herrera, X., Ocampo-Ruiz, A. L., Martinez de la Escalera, G., Clapp, C., & Macotela, Y. , Obesity-derived alterations in the lactating mammary gland: focus on prolactin, Molecular And Cellular Endocrinology, October 2023; 559, 111810 online

14. Luzardo-Ocampo, I., Dena-Beltrán, J. L., Ruíz-Herrera, X., Ocampo-Ruiz, A. L., Martinez de la Escalera, G., Clapp, C., & Macotela, Y. , Obesity-derived alterations in the lactating mammary gland: focus on prolactin, Molecular And Cellular Endocrinology, October 2023; 559, 111810 online

15. Robles JP, Zamora M, Garcia-Rodrigo JF, Perez AL, Bertsch T, Martínez de la Escalera G, Triebel J, Clapp C. , The apoptotic, inflammatory, and fibrinolytic actions of vasoinhibin are in a motif different from its antiangiogenic HGR motif. , BioRxiv, October 2023 online

16. Núñez-Amaro CD, López M, Adán-Castro E, Robles-Osorio ML, García-Franco L, García-Roa M, Villalpando-Robles Y, Ramírez-Neria P, Pineiro N, Rubio-Mijangos JF, Sánchez J, Ramírez-Hernández G, Siqueiros-Márquez L, Díaz-Lezama N, López-Star E, Bertsch T, Martínez de la Escalera G, Triebel J, Clapp C. , Levosulpiride for the treatment of diabetic macular oedema: A phase 2 randomized clinical trial. , EYE, March 2023, 1-9

17. Ruiz-Herrera X, Luzardo-Ocampo I, Martínez de la Escalera G, Clapp C, Macotela Y. , Differentiated mouse adipocytes in primary culture: A model of insulin resistance. , JOVE, February 2023; 192, e63979

18. Ruiz-Herrera X, Luzardo-Ocampo I, Martínez de la Escalera G, Clapp C, Macotela Y. , Differentiated mouse adipocytes in primary culture: A model of insulin resistance. , JOVE, February 2023; 192, e63979

19. Clapp C, Ortíz G, García-Rodrigo JF, Ledesma-Colunga MG, Martínez-Díaz F, Adán N, Martínez de la Escalera G., Dual roles of prolactin and vasoinhibin in inflammatory arthritis, Frontiers in Endocrinology, November 2022; 13, 905756

20. Macotela Y, Ruíz-Herrera X, Vázquez D, Ramírez-Hernández G, Martínez de la Escalera G, Clapp C. , The beneficial metabolic effects of prolactin. , Frontiers in Endocrinology, October 2022; 13, 103389

21. Macotela Y, Ruíz-Herrera X, Vázquez D, Ramírez-Hernández G, Martínez de la Escalera G, Clapp C. , The beneficial metabolic effects of prolactin. , Frontiers in Endocrinology, October 2022; 13, 103389

22. Adán-Castro E, Siqueiros-Márquez L, Ramírez-Hernández G, Díaz-Lezama N, Ruiz-Herrera X, Nuñez FF, Nuñez-Amaro CD, Robles-Osorio ML, Bertsch T, Triebel J, Martínez de la Escalera G, Clapp C. , Sulpiride-induced hyperprolactinemia increases retinal vasoinhibin and protects against diabetic retinopathy in rats. , Journal of Neuroendocrinology: Translational and Clinical Neuroendocrinology, August 2022; 34, e13091

23. Martínez de la Escalera G, Macotela Y, Clapp C. , A new experimental tool towards understanding the regulation of human prolactin secretion and functions. , Endocrinology, August 2022; 163(4), 1-2

24. Martínez de la Escalera G, Macotela Y, Clapp C. , A new experimental tool towards understanding the regulation of human prolactin secretion and functions. , Endocrinology, August 2022; 163(4), 1-2

25. Ortíz G, Ledesma-Colunga MG, Zhijian Wu Z, García-Rodrigo JF, Adán N, Martínez-Díaz F, de Los Ríos EA, López-Barrera F, Martínez de la Escalera G, Clapp C. , Vasoinhibin is generated and promotes inflammation in mild antigen-induced arthritis. , Endocrinology, August 2022; 163(5), 1-12

26. Ortíz G, Ledesma-Colunga MG, Zhijian Wu Z, García-Rodrigo JF, Adán N, Martínez-Díaz F, de Los Ríos EA, López-Barrera F, Martínez de la Escalera G, Clapp C. , Vasoinhibin is generated and promotes inflammation in mild antigen-induced arthritis. , Endocrinology, August 2022; 163(5), 1-12

27. Robles JP, Zamora M, Martínez de la Escalera G, Clapp C. , The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin α5β1 and NF-κB signaling, Journal Of Biological Chemistry, March 2022; 298(3), 101695

28. Robles JP, Zamora M, Martínez de la Escalera G, Clapp C. , The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin α5β1 and NF-κB signaling, Journal Of Biological Chemistry, March 2022; 298(3), 101695

29. Robles JP, Zamora M, Siqueiros-Marquez L, Adan-Castro E, Ramirez-Hernadez G, Nuñez FF, Lopez-Casillas F, Millar RP, Bertsch T, Martínez de la Escalera G, Tiebel J, Clapp C. , The HGR motif is the antiangiogenic determinant of vasoinhibin: implications for a therapeutic orally active oligopeptide. , Angiogenesis, March 2022; 25, 57-70

30. Friedrich C, Neugebauer L, Zamora M, Robles JP, Martínez de la Escalera G, Clapp C, Bertsch T, Triebel J. , Plasmin generates vasoinhibin-like peptides by cleaving prolactin and placental lactogen. , Molecular And Cellular Endocrinology, November 2021; 538(111471)

31. Robles JP, Zamora M, Martínez de la Escalera G, Clapp C. , The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin α5β1 and NF-κB. , BioRxiv, November 2021

32. Zamora M, Robles JP, Aguilar MB, Romero-Gómez SJ, Bertsch T, Martínez de la Escalera G, Tiebel J, Clapp C. , Thrombin cleaves prolactin into a potent 5.6 kDa vasoinhibin: Implication for tissue repair. , Endocrinology, August 2021; 162, 1-15

33. Ramírez-Hernández G., Adán-Castro E., Díaz-Lezama N., Ruiz-Herrera X, Martínez de la Escalera G., Macotela Y, Clapp C. , Global deletion of the prolactin receptor aggravates streptozotocin-induced diabetes in mice. , Frontieres in Endocrinology (Lausanne), May 2021; 12, 619696

34. Müller N, Robles JP, Zamora M, Ebnet J, Markl-Hahn H, Martínez de la Escalera G, Clapp C, Bertsch, Tiebel J. , Development of vasoinhibin-specific monoclonal antibodies, Frontieres in Endocrinology (Lausanne), March 2021; 12, 645085

35. Núñez-Amaro, D., Moreno-Vega, A.I., Adán-Castro, E., Zamora, M., García-Franco, R., Ramírez-Neria, P., García-Roa, M., Villalpando, Y., Robles, J.P., Ramírez-Hernández, G., López, M., Sánchez, J., López-Star, E., Bertsch, T, Martínez de la Escalera, G., Robles-Osorio, M.L., Triebel, J., Clapp, C. , Levosulpiride increases the levels of prolactin and antiangiogenic vasoinhibin in the vitreous of patients with proliferative diabetic retinopathy. , Translational Vision Science and Technology, November 2020; 9(9), 27

36. Ortiz, G., Ledesma-Colunga, M.G., Wu, Z., García-Rodrigo, J.F., Adán, N., Martínez de la Escalera, G., Clapp, C. , Vasoinhibin reduces joint inflammation, bone loss, and the angiogenesis and vasopermeability of the pannus in murine antigen-induced arthritis. , Laboratory Investigation, November 2020; 100, 1068-1079

37. Aroña, R.M., Arnold, E., Macías, F., López-Casillas, F., Clapp, C., Martínez de la Escalera, G. , Vasoinhibin generation and effect on neuronal apoptosis in the hippocampus of late mouse embryos. , AMERICAN JOURNAL OF PHYSIOLOGY: Regulatory, Integrative and Comparative Physiology, April 2020; 318(4), R760-771

38. Vázquez-Membrillo, M., Siqueiros-Márquez, L., Núñez, F.F., Díaz-Lezama, N., Adán-Castro, E., Ramírez-Hernández, G., Adán, N., Macotela, Y., Martínez de la Escalera, G., Clapp, C. , Prolactin stimulates the vascularization of the retina in newborn mice exposed to hyperoxia, Journal Of Neuroendocrinology, April 2020; e12858

39. Triebel, J., Schauer, N., Zamora, M., Moreno-Vega, A.I., Martínez de la Escalera, G., Clapp, C., Bertsch, T. , Matrix metalloproteases and cathepsin D in human serum do not cleave prolactin to generate vasoinhibin. , Clinical Laboratory, March 2020; 66, 877-866

40. Ponce, A.J., Galván-Salas, T., Lerma-Alvarado, R.M., Ruíz-Herrera, X., Cárdenas, L.E., Hernández, T., Valencia, R., Martínez de la Escalera, G., Clapp, C., Macotela, Y. , Low prolactin levels associate with insulin resistance and visceral adipocyte hypertrophy in humans. , Endocrine, February 2020; 67, 331-343

41. Arnold, E., Thebault, S., Aroña, R.M., Martínez de la Escalera, G., Clapp, C. , Prolactin mitigates deficiencies of retinal function associated with aging. , Neurobiology of Aging, January 2020; 85, 38-48

42. Lenke, L., Martínez de la Escalera, G., Clapp, C., Bertsch, T., Triebel, J. , A dysregulation of the prolactin/vasoinhibin axis appears to contribute to preeclampsia. , Frontiers in Endocrinology, January 2020; 10, 893

43. Melo, Z., Castillo, X., Moreno-Carranza, B., Ledesma-Colunga, M.G., López-Casillas, F., Ruíz-Herrera, X., Clapp, C., Martínez de la Escalera, G. , Vasoinhibin suppresses nerve growth factor-induced differentiation and survival of PC12 pheochromocytoma cells. , Neuroendocrinology, August 2019; 109(2), 152-164

44. Moreno-Carranza, B., Robles, J.P., Cruces-Solís, H., Ferrer-Ríos, M.G., Aguilar-Rivera, E., Yupanki, M., Martínez de la Escalera, G., Clapp, C. , Sequence optimization and glycosylation of vasoinhibin: Pitfalls of recombinant production. , Protein Expression And Purification, April 2019; 161, 49-56

45. Triebel, J., Robles, J.P., Zamora, M., Martínez de la Escalera, G., Bertsch, T, Clapp, C. , Regulator of angiogenesis and vascular function: A 2019 update of the vasoinhibin nomenclature. , Frontiers in Endocrinology, February 2019; 10, 214

46. Robles, J.P., Zamora, M., Velasco-Bolom, J.L., Tovar, M., Garduño-Juárez, R., Bertsch, T., Martínez de la Escalera, G., Triebel, J., Clapp, C. , Vasoinhibins comprise a three-helix bundle and their antiangiogenic domain is located within the first 79 residues. , Scientific Reports, November 2018; 8(17111), 1-17

47. De los Ríos EA, Ruiz-Herrera X, Tinoco-Pantoja V, López-Barrera F, Martínez de la Escalera G, Clapp C, Macotela Y. , Impaired prolactin actions mediate altered offspring metabolism induced by maternal high fat feeding during lactation. , The FASEB Journal, June 2018; 32(6), 3457-3470

48. Moreno-Carranza B, Bravo-Manríquez M, Baez A, Ledesma-Colunga MG, Ruiz-Herrera X, Reyes-Ortega P, de los Ríos EA, Macotela Y, Martínez de la Escalera G, Clapp C., Prolactin regulates liver growth during postnatal development in mice. , American Journal Of Physiology-Cell Physiology, June 2018; 314(6), R902-R908

49. Robles-Osorio, L., García-Franco, R., Núñez-Amaro, D., Mira-Lorenzo, X., Ramírez-Neria, P., Hernández, W., López-Star, E., Bertsch, T., Martínez de la Escalera, G., Triebel, J., Clapp, C. , Basis and design of a randomized clinical trial to evaluate the effect of levosulpiride on retinal alterations in patients with diabetic retinopathy and diabetic macular edema. , Frontiers in Endocrinology, May 2018; 9(242), 1-8

50. Castillo, X., Melo, Z., Varela-Echevarría, A., Tamáriz, E., Aroña, R.M., Arnold, E., Clapp, C., Martínez de la Escalera, G. , Vasoinhibins suppresses the ability of NGF and VEGF to stimulate neurite growth in rat primary sensory neurons. , Neuroendocrinology, March 2018; 106(3), 221-233

51. Triebel, J., Martínez de la Escalera, G., Clapp, C., Bertsch, T. , From bench to bedside: translating the prolactin/vasoinhibin axis. , Frontiers in Endocrinology, December 2017; 8, 342

52. Triebel, J., Friedrich, C.J., Leuchs, A., Martínez de la Escalera, G., Clapp, C., Bertsch, T. , Human prolactin point mutations and their projected effect on vasoinhibin generation and vasoinhibin-related diseases., Frontiers in Endocrinology, November 2017; 8, 294

53. Triebel, J., Martínez de la Escalera, G., Clapp, C., Bertsch, T. , Vasoinhibins may contribute to postpartum depression. , Frontiers in Psychiatry, October 2017; 8, 167

54. Ledesma-Colunga, M.G., Adan N., Ortiz, G., Solis-Gutierrez, M., López-Barrera, F., Martínez de la Escalera, G., Clapp, C. , Prolactin blocks the expression of receptor activator of nuclear factor kB ligand and reduces osteoclastogenesis and bone loss in murine inflammatory arthritis. , Arthritis Research & Therapy, August 2017; 19, 93-109

55. Triebel, J., Clapp, C., Martínez de la Escalera, G., Bertsch, T. , Vasoinhibin serum levels are required to demonstrate their role in peripartum cardiomyopathy etiopathology, Journal of the American Society for Artificial Internal Organs, August 2017; 63, e50

56. Triebel, J., Clapp, C., Martínez de la Escalera, G., Bertsch, T. , Commentary: Prolactin Alters Blood Pressure by Modulating the Activity of Endothelial Nitric Oxide Synthase, Frontiers in Endocrinology, May 2017; 8, 105

57. Triebel, J., Clapp, C., Martínez de la Escalera, G., Bertsch, T. , Remarks on the prolactin hypothesis of peripartum cardiomyopathy, Frontiers in Endocrinology, April 2017; 8, 77

58. Zepeda-Romero, L.C., Vázquez-Membrillo, M., Adán-Castro, E., Gómez-Aguayo, F., Gutiérrez-Padilla, J.A., Angulo-Castellanos, E., Barrera de León, J.C., González-Bernal, C., Quezada-Chalita, A., Meza-Anguiano, A., Díaz-Lesama, N., Martínez de la Escalera, G., Triebel, J., Clapp, C. , Higher prolactin and vasoinhibin serum levels associated with incidence and progression of retinopathy of prematurity. , Pediatric Research, March 2017; 81(3), 473-479

59. Ruíz-Herrera, X., De los Ríos, E.A., Díaz, J.M., López-Barrera, F., Lemini, M., Arnold, E., Martínez de la Escalera, L., Lerma, R., Martínez de la Escalera, G., Clapp, C., Macotela, Y. , Prolactin promotes adipose tissue fitness and insulin sensitivity in obese males., Endocrinology, January 2017; 158(1), 56-68

60. Clapp, C., Adán, N., Ledesma-Colunga, M.G., Solís-Gutiérrez, M., Triebel, J., Martínez de la Escalera, G. , The role of the prolactin/vasoinhibin axis in rheumatoid arthritis: An integrative overview. , Cellular and Molecular Life Sciences , July 2016; 73, 2929-2948

61. Díaz-Lezama, N., Wu, Z., Adán-Castro, E., Vázquez-Membrillo, M., Arredondo-Zamarripa, D., Ledesma-Colunga, M.G., Moreno-Carranza, B., Martínez de la Escalera, G., Colosi, P. and Clapp, C. , Diabetes enhances the efficacy of AAV2 vectors in the retina: therapeutic effect of AAV2 encoding vasoinhibins and soluble VEGF receptor 1., Laboratory Investigation, March 2016; 96, 283-295

62. Triebel, J., Bertsch, T., Bolheimer, C., Ríos-Barrera, D., Pearce C.F., Hüfner, M., Martínez de la Escalera, G., Clapp, C. , Principles of the prolactin/vasoinhibin axis. , AMERICAN JOURNAL OF PHYSIOLOGY: Regulatory, Integrative and Comparative Physiology, November 2015; 309, R1193-R1203

63. Triebel, J., Moreno-Vega, A.I., Vázquez-Membrillo, M., Nava, G., García-Franco, R., López-Star, E., Baldivieso-Hurtado, O., Ochoa, D., Macotela, Y., Bertsch, T., Martínez de la Escalera, G., Clapp, C. , High prolactin excretion in patients with diabetes mellitus and impaired renal function., Clinical Laboratory, November 2015; 61, 709-716

64. Lemini, M., Ruiz-Herrera, X., Ledesma-Colunga, M.G., Díaz-Lezama, N., De los Ríos, E., López-Barrera, F., Mendez, I., Martínez de la Escalera, G., Macotela, Y., Clapp, C. , Prolactin anterior pituitary expression and circulating levels are reduced in obese and diabetic rats: Role of TGFβ and TNFα., AMERICAN JOURNAL OF PHYSIOLOGY: Regulatory, Integrative and Comparative Physiology, October 2015; 308, R792-R799

65. Triebel, J., Bertsch, T., Martínez de la Escalera, G., Clapp, C. Frontiers in Endocrinology, On the path towards classifying hormones of the vasoinhibin-family. , Frontiers in Endocrinology, February 2015; 6, 1-2

66. Clapp, C., Thebault, S., Macotela, Y., Moreno-Carranza, B., Triebel, J., Martínez de la Escalera, G. , Regulation of blood vessels by prolactin and vasoinhibins. , Advances In Experimental Medicine And Biology, January 2015; 846, 83-95

67. Adán, N., Ledesma-Colunga, M.G., Reyes-López, A.L., Martínez de la Escalera, G., Clapp, C. , Arthritis and prolactin: A phylogenetic viewpoint. , General And Comparative Endocrinology, September 2014; 203, 132-136

68. Zamorano, M., Ledesma-Colunga, M.G., Adán, N., Vera-Massieu, C., Lemini, M., Méndez, I., Moreno-Carranza, B., Neumann, I.D., Thebault, S., Torner, L., Martínez de la Escalera, G., Clapp, C. , Vasoinhibin increases anxiety- and depression-related behaviors. , Psychoneuroendocrinology, June 2014; 44, 123-132

69. Garcia, C., Nuñez-Arita, R.E., Thebault, S., Arredondo-Zamarripa, D., Jeziorski, M.C., Martínez de la Escalera, G., Clapp, C. , Requirement of phosphorytable endothelial nitric oxide synthase at Ser-1177 for vasoinhibin-mediated antiangiogenic effects. , Endocrine, February 2014; 45(2), 263-270

70. Arnold, E., Thebault, S., Baeza-Cruz, G., Quintanar-Stephano, A., Condés-Lara, M., Rojas-Piloni, G., Binart, N., Martínez de la Escalera, G., Clapp, C., The hormone prolactin is a novel endogenous trophic factor able to regulate reactive glia and to limit retinal degeneration. , Journal Of Neuroscience, January 2014; 34(5), 1868-1878

71. Moreno-Carranza, B., Goya-Arce, M., Vega, C., Adán, N., Triebel, J., Lopez-Barrera, F., Quintanar-Stephano, A., Binart, N., Martínez de la Escalera, G., Clapp, C. , Prolactin promotes normal liver growth, survival, and regeneration in rodents: role of Interleukin-6 and Suppressor of Cytokine Signaling-3. , AMERICAN JOURNAL OF PHYSIOLOGY: Regulatory, Integrative and Comparative Physiology, October 2013; 305, 720-726

72. Adán, N., Guzmán-Morales, J., Ledesma-Colunga, G., Perales-Canales, S.I., Quintanar-Stephano, A., López-Barrera, F., Méndez, I., Moreno-Carranza, B., Triebel, J., Binart, N., Martínez de la Escalera, G., Thebault, S., Clapp, C. , Prolactin promotes cartilage survival and attenuates inflammation in rheumatoid arthritis. , Journal Of Clinical Investigation, September 2013; 123(9), 3902-3913

73. Noris, G., Santana, C., Muñoz, M. L., Majluft-Cruz, A., Meraz-Ríos, M.A., Magaña, J.J., Quezada, R., Revilla, M.C., Martínez-Salas, S., Xihuitl, S., Martínez de la Escalera, G., Calderón-Aranda, E., Díaz-Badillo, A., Gómez, R., Mexican mestizo population sub-structure: effects on genetic and forensic statistical parameters, Molecular Biology Reports, December 2012; 39(12), 10139-10156

74. Clapp, C., Martínez de la Escalera, L., Martínez de la Escalera, G. , Prolactin and blood vessels: a comparative endocrinology perspective., General And Comparative Endocrinology, May 2012; 176(3), 336-340

75. Ramírez, M., Wu, Z., Moreno-Carranza, B., Jeziorski, M.C., Arnold, E., Díaz-Lezama, N., Martínez de la Escalera, G., Colosi, P., Clapp, C. , Vasoinhibin gene transfer by Adeno-Associated Virus type 2 protects against VEGF- and diabetes-induced retinal vasopermeability., Investigative Ophthalmology & Visual Science, November 2011; 52(11), 8944-8950

76. Clapp, C. and Martínez de la Escalera, G. , Editorial Focus: peripheral regulation of prolactin by oxytocin: focus on “systemic oxytocin induces a prolactin secretory rhythm via the pelvic nerve in ovariectomized rats”. , AMERICAN JOURNAL OF PHYSIOLOGY: Regulatory, Integrative and Comparative Physiology, July 2011; 301(7), 674-675 online

77. Thebault, S., González, C., García, C., Arredondo Zamarripa, D., Nava, G., Vaca, L., Martínez de la Escalera, G., Clapp, C. , Vasoinhibins prevent bradykinin-stimulated endothelial cell proliferation by inactivating eNOS via reduction of both intracellular Ca2+ levels and eNOS phosphorylation at Ser(1179). , Pharmaceuticals, July 2011; 4(7), 1052-1069 online

78. Triebel, J., Macotela, Y., Martínez de la Escalera, G., Clapp, C. , Prolactin and Vasoinhibins: endogenous players in diabetic retinopathy. , IUBMB Life, March 2011; 63(3), 806-810

79. Arnold E, Rivera JC, Thebault S, Moreno-Páramo D, Quiroz-Mercado H, Quintanar-Stéphano A, Binart N, Martínez de la Escalera G, Clapp C., High levels of serum prolactin protect against diabetic retinopathy by increasing ocular vasoinhibins. , Diabetes, December 2010; 59(12), 3192-3197

80. Vega C, Moreno-Carranza B, Zamorano M, Quintanar-Stephano A, Méndez I, Thebault S, Martínez de la Escalera G, Clapp C. , Prolactin promotes oxytocin and vasopressin release by activating neuronal nitric oxide synthase in the supraoptic and paraventricular nuclei. , AMERICAN JOURNAL OF PHYSIOLOGY: Regulatory, Integrative and Comparative Physiology, December 2010; 299(6), 1701-1708

81. Méndez I, Vega C, Zamorano M, Moreno-Carranza B, Martínez de la Escalera G, Clapp C., Vasoinhibins and the pituitary gland., Frontiers Of Hormone Research, March 2010; 38(1), 184-189

82. Castilla, A., García, C., Cruz-Soto, M., Martínez de la Escalera, G., Thebault, S., Clapp, C., Prolactin in ovarian follicular fluid stimulates endothelial cell proliferation. , Journal of Vascular Research, January 2010; 47(1), 45-53

83. Cruz-Soto, M., Cosío, G., Jeziorski, M.C., Vargas-Barroso, V., Aguilar, M.B., Cárabez, A., Berger, P., Satfig, P., Thebault, S., Martínez de la Escalera, G., Clapp, C. , Cathepsin D is a primary protease for the generation of adenohypophyseal vasoinhibins: Cleavage occurs within the prolactin secretory granules., Endocrinology, December 2009; 150(12), 5446-5454

84. Clapp, C., Thebault, S., Jeziorski, M.C., Martínez de la Escalera, G. , Peptide hormone regulation of angiogenesis. , Physiological Reviews, October 2009; 89(4), 1177-1215

85. Clapp C, Thebault S, Arnold E, García C, Rivera JC, Martínez de la Escalera G., Vasoinhibins: Novel inhibitors of ocular angiogenesis, American Journal Of Physiology, Endocrinology And Metabolism, October 2008; 295(4), 772-778

86. García, C., Aranda, J., Arnold, E., Thebault, S., Macotela, J., López-Casillas, F., Mendoza, V., Quiroz-Mercado, H., Lin, S.H., Martínez de la Escalera, G., Clapp, C., Vasoinhibins prevent increased retinal vasopermeability associated with diabetic retinopathy via protein phosphatase 2A-dependent eNOS inactivation, Journal Of Clinical Investigation, June 2008; 118(6), 2291-2300

87. Rivera, J.C., Aranda, J., Riesgo, J., Nava, G., Thebault, S., López-Barrera, F., Ramírez, M., Martínez de la Escalera, G., Clapp, C, Expression and cellular localization of prolactin and the prolactin receptor in mammalian retina., Experimental Eye Research, June 2008; 86(2), 314-321

88. Clapp, C., Thebault, S, Martínez de la Escalera, G., Role of prolactin and vasoinhibins in the regulation of vascular function in mammary gland., Journal Of Mammary Gland Biology And Neoplasia, March 2008; 13(1), 55-67

89. Jacobi, J.S., Martin, C., Nava, G., Jeziorski, M.C., Clapp, C., Martínez de la Escalera, G. , 17β-estradiol directly regulates the expression of adrenergic and kisspeptin/GPR54 system in GT1-7 GnRH neurons. , Neuroendocrinology, 2007; 86, 260-269

90. Martin, C., Jacobi, J.S., Nava, G., Jeziorski, M.C., Clapp, C., Martínez de la Escalera, G. , GABA Inhibition of Cyclic AMP Production in Immortalized GnRH Neurons is Mediated by Calcineurin-Dependent Dephosphorylation of Adenylyl Cyclase 9. , Neuroendocrinology, 2007; 85, 257-266

91. Clapp C., Thebault S., Martínez de la Escalera G., Hormones and postpartum cardiomyopathy, Trends In Endocrinology And Metabolism, November 2007; 18(9), 329-330

92. González C., Parra A., Ramírez-Pulido J., García C., Rivera J.C., Macotela Y., Aranda J., Lemini M., Arias J., Ibarguengoitia F., Martínez de la Escalera G., Clapp C., ELEVATED VASOINHIBINS MAY CONTRIBUYE TO ENDOTELIAL CELL DYSFUNCTION AND LOW BIRTH WEIGHT IN PREECLAMPSIA., Laboratory Investigation, January 2007; 87(0), 1009-1017

93. Loske A., Martínez de la Escalera G., Armenta E., Varela-Echavarría A., Acoustic shock waves as a cell-permeabilization method, Revista De Acústica, January 2007; 38(0), 3-4

94. Moreno-Páramo, D., Rivera, J.C., Aranda, J., Salazar, N., Arnold, E., Quiróz-Mercado, H., Martínez de la Escalera, G., Clapp, C., RETINOPATIA DIABETICA Y VASOINHIBINAS., Revista de Investigacion Clinica, January 2007; 19(0), 290-297

95. Macotela, Y., Aguilar, M., Guzmán-Morales, J., Rivera, J.C., Zermeño, C., López-Barrera, F., Nava, G., Lavalle, C., Martínez de la Escalera G., Clapp, C. , Matrix metalloproteases from chondrocytes generate antiangiogenic 16K- prolactin. , Journal Of Cell Science, 2006; 119, 1790-1800

96. Zermeño, C., Guzmán-Morales, J., Macotela, Y., Nava, G., López-Barrera, F., Kouri, J., Lavalle, C., Martínez de la Escalera, G., and Clapp, C. , Prolactin inhibits the apoptosis of chondrocytes induced by serum-starvation. , Journal Of Endocrinology, 2006; 189, 1-8

97. Armenta-Ruiz E., Varela-Echavarría A., Martínez de la Escalera G., Loske-Mehling A.M., Transfeccion de celulas por medio de ondas de choque, Revista Mexicana De Física, October 2006; 52(0), 352-358

98. Clapp C, Aranda J, González C, Jeziorski MC, Martínez de la Escalera G, Vasoinhibins: endogenous regulators of angiogenesis and vascular function, Trends In Endocrinology And Metabolism, October 2006; 17(0), 301-307

99. Clapp C, González C, Macotela Y, Aranda J, Rivera JC, García C, Guzmán-Morales J, Zamorano M, Vega C, Martin C, Jeziorski MC, Martínez de la Escalera G, Vasoinhibins: a family of N-terminal prolactin fragments that inhibit angiogenesis and vascular function, Frontiers Of Hormone Research, January 2006; 35(0), 64-73

100. Clapp C., Martínez de la Escalera G., AQUAPORIN-1: A NOVEL PROMOTER OF TUMOR ANGIOGENESIS., Trends In Endocrinology And Metabolism, January 2006; 17(0), 1-2

101. Gutiérrez de la Barrera M., Trejo B., Luna-Pérez P., López-Barrera F., Martínez de la Escalera G., Clapp C., OPPOSITE ASSOCIATION OF SERUM PROLACTIN AND SURVIVAL IN PATIENTS WITH COLON AND RECTAL CARCINOMAS: INFLUENCE OF PREOPERATIVE RADIOTHERAPY., Digestive Diseases And Sciences, January 2006; 51(0), 54-62

102. Aranda J., Rivera J. C., Jeziorski M. C., Riesgo J., Nava G., López-Barrera F., Quiroz-Mercado H., Berger P., Martínez de la Escalera G. and Clapp C, Prolactins are natural inhibitors of angiogenesis in the retina, Investigative Ophthalmology & Visual Science, January 2005; 46(0), 2947-2953

103. Montes de Oca P., Macotela Y., Nava G., López-Barrera F., Martínez de la Escalera G., Clapp C., PROLACTIN STIMULATES INTEGRIN-MEDIATED ADHESION OF CIRCULATING MONONUCLEAR CELLS TO ENDOTHELIAL CELLS., Laboratory Investigation, January 2005; 85(0), 633-642

104. Dueñas Z., Rivera J.C., Quiróz-Mercado H., Aranda J., Macotela Y., Montes de Oca P., López-Barrera F., Nava G., Guerrero J.L., Suárez A., De Regil M., Martínez de la Escalera G., Clapp C., Prolactin in the eye of patients with retinopathy of prematurity: Implications for vascular regression., Investigative Ophthalmology & Visual Science, January 2004; 45(7), 2049-2055

105. González C., Corbacho A.M., Eiserich J.P., García C., López-Barrera F., Morales-Tlalpan V., Barajas-Espinosa A., Díaz-Muñoz M., Rubio R., Lin S-H., Martínez de la Escalera G., Clapp C., 16K-Prolactin inhibits activation of endotelial nitric oxide synthase, intracellular calcium mobilization and endothelium-dependent vasorelaxation. , Endocrinology, January 2004; 145, 5714-5722

106. Corbacho A.M., Macotela Y., Nava G., Eiserich J.P., Cross C.E, Martínez de la Escalera G., Clapp C., CYTOKINE INDUCTION OF PROLACTIN RECEPTORS MEDIATES PROLACTIN INHIBITION OF NITRIC OXIDE SYNTHESIS IN PULMONARY FIBROBLASTS., Febs Letters, January 2003; 544(0), 171-174

107. Cosío G, Jeziorski MC, López-Barrera F, Martínez de la Escalera G, Clapp C, Hypoxia inhibits expression of prolactin and secretion of cathepsin-D by the GH4C1 pituitary cell line, Laboratory Investigation, January 2003; 83(11), 1627-1636

108. Mejía S, Torner LM, Jeziorski MC, González C, Morales MA, Martínez de la Escalera G, Clapp C, Prolactin and 16K prolactin stimulate the release of vasopressin by a direct effect on the hypothalamo-neurohypophyseal system, Endocrine, January 2003; 20(0), 155-162

109. Cajero-Juárez M., Avila B., Ochoa A., Garrido-Guerrero E., Varela-Echavarría A., Martínez de la Escalera G., Clapp C., Immortalization of bovine umbilical vein endothelial cells: a model for the study of vascular endothelium, European Journal Of Cell Biology, October 2002; 81(0), 1-8

110. Corbacho A.M., Martínez de la Escalera G., Clapp C., ROLES OF PROLACTIN AND RELATED MEMBERS OF THE PROLACTIN/GROWTH HORMONE/PLACENTAL LACTOGEN FAMILY IN ANGIOGENESIS., Journal Of Endocrinology, January 2002; 173(0), 219-238

111. Macotela Y., Mendoza C., Cosío G., Eiserich J.P., Zentella A., Martínez de la Escalera G., Clapp C., 16K PROLACTIN INDUCES NF-KB ACTIVATION IN PULMONARY FIBROBLASTS., Journal Of Endocrinology, January 2002; 175(0), R13-R18

112. Beltrán-Parrazal, L., Noris, G., Clapp, C., and Martínez de la Escalera, G. , GABA inhibition of immortalized GnRH neuronal excitability involves GABAA receptors negatively coupled to cyclic AMP formation. , Endocrine, 2001; 14, 189-195

113. Cruz J., Aviña-Zubieta A., Martínez de la Escalera G., Clapp C., Lavalle C., MOLECULAR HETEROGENEITY OF PROLACTIN IN THE PLASMA OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS., Arthritis Rheumatism, January 2001; 44(0), 1331-1335

114. Martínez de la Escalera G., Clapp C., REGULATION OF GONADOTROPIN-RELEASING HORMONE SECRETION: LESSONS FROM GT1 IMMORTAL GNRH NEURONS., Archives Of Medical Reseach, January 2001; 32(0), 486-498

115. Ochoa A., Montes de Oca P., Rivera J.C., Dueñas Z., Nava G., Martínez de la Escalera G., Clapp C., EXPRESSION OF PROLACTIN GENE AND SECRETION OF PROLACTIN BY RAT RETINAL CAPILLARY ENDOTHELIAL CELLS., Investigative Ophthalmology & Visual Science, January 2001; 42(0), 1639-1645

116. Corbacho A.M., Macotela Y., Nava G., Torner L., Dueñas Z., Noris G.F., Morales M.A., Martínez de la Escalera G., Clapp C., HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS EXPRESS MULTIPLE PROLACTIN-LIKE ISOFORMS., Journal Of Endocrinology, January 2000; 166(0), 53-62

117. Corbacho A.M., Nava G., Eiserich J.P., Noris G.F., Macotela Y., Struman I., Martínez de la Escalera G., Freeman B.A., Clapp C., PROTEOLYTIC CLEAVAGE CONFERS NITRIC OXIDE SYNTHASE INDUCTING ACTIVITY UPON PROLACTIN., Journal Of Biological Chemistry, January 2000; 275(0), 13183-13186

118. Flores J.A., Véliz F. G., Pérez-Villanueva J.A., Martínez de la Escalera G., Chemineau P., Poindron. P., Malpaux B., Delgadillo J.A., MALE SEXUAL ACTIVITY IS THE LIMITING FACTOR OF EFFICIENCY IN MALE EFFECT DURING SEASONAL ANESTRUS IN FEMALE GOATS., Biology Of Reproduction, January 2000; 62(0), 1409-1414

119. Hernández, M.M., García Ferreiro, R.E., García, D.E., Hernández, M.E., Clapp, C. and Martínez de la Escalera, G. , Potentiation of prolactin secretion following lactotrope escape from dopamine action: I. Dopamine withdrawal augments L-type Ca2+ channels. , Neuroendocrinology, February 1999; 70, 20-30

120. Dueñas Z., Torner L., Corbacho Ana. M., Ochoa A., Gutiérrez-Ozpina G., Barrios F., Berger P., Martínez de la Escalera G., Clapp C., INHIBITION OF RAT CORNEAL ANGIOGENESIS BY 16-KDA PROLACTIN AND BY ENDOGENOUS PROLACTIN-LIKE MOLECULES., Investigative Ophthalmology & Visual Science, January 1999; 40(11), 2498-2505

121. Hernández M.E., Díaz M., Hernández M.M., Clapp C., Martínez de la Escalera G., Potentiation of prolactin secretion following lactotrope escape from dopamine action. II. Phosphorylation of the α1 subunit of L-type, voltage-dependent calcium channels, Neuroendocrinology, January 1999; 70(0), 31-42

122. Torner L., Nava G., Dueñas Z., Corbacho A., Mejía S., López F., Cajero M., Martínez de la Escalera G., Clapp C., CHANGES IN THE EXPRESSION OF NEUROHYPOPHYSEAL PROLACTINS DURING THE ESTROUS CYCLE AND AFTER ESTROGEN TREATMENT., Journal Of Endocrinology, January 1999; 161(3), 423-432

123. Trueta C., Díaz M., Vaca L., Clapp C., Martínez de la Escalera G., Functional uncoupling between intracellular calcium dynamics and secretion in the αT3-1 gonadotropic cells, Journal Of Cellular Physiology, January 1999; 179(0), 347-357

124. CLAPP, C., LOPEZ-GOMEZ, F., NAVA, G., MACOTELA, Y., TORNER, L., CORBACHO, A., ACOSTA, E., DUEÑAS, Z., MORALES, M.A., MARTINEZ DE LA ESCALERA, G., EXPRESSION OF PROLACTIN mRNA AND PROLACTIN-LIKE PROTEINS IN ENDOTHELIAL CELLS. EVIDENCE FOR AUTOCRINE EFFECTS., Journal Of Endocrinology, January 1998; 158(0), 137-144

125. Clapp C., Martínez de la Escalera G., PROLACTINS: NOVEL REGULATORS OF ANGIOGENESIS., News In Physiological Sciences, January 1997; 12(0), 40-46

126. Mejía S., Morales M. A., Zetina M.E., Martínez de la Escalera G., Clapp C., IMMUNOREACTIVE PROLACTINS CO-LOCALIZE WITH VASOPRESSIN IN NEURONS OF THE HYPOTHALAMIC PARAVENTRICULAR AND SUPRAOPTIC NUCLEI., Neuroendocrinology, January 1997; 66(0), 151-159

127. Ochoa A., Domenzáin C., Clapp C., Martínez de la Escalera G., DIFFERENTIAL EFFECTS OF BFGF, EGF, TGF-A AND IGF-I ON A HYPOTHALAMIC GNRH NEURONAL CELL LINE., Journal Of Neuroscience Research, January 1997; 49(0), 739-749

128. Trueta C., Salgado Z., Clapp C., Martínez de la Escalera G., THE CATECHOLAMINERGIC STIMULATION OF GONADOTROPIN-RELEASING HORMONE RELEASE BY GT1-1 CELLS DOES NOT INVOLVE PHOSPHOINOSITIDE HYDROLYSIS., Life Sciences, January 1996; 58(0), 1453-1459

129. López, F., Torner, L., Mejía, S., Martínez de la Escalera, G. and Clapp, C., Immunoreactive prolactins of the neurohypophyseal system display actions characteristic of adenohypophyseal and 16K prolactin., Endocrine, April 1995; 3, 573-578

130. Martínez de la Escalera G., Choi A.L.H., Weiner. R. I., SIGNALLING PATHWAYS INVOLVED IN THE PULSATILE RELEASE OF GNRH FROM GT1-1 CELLS., Neuroendocrinology, January 1995; 61(0), 310-317

131. Noris G.F., Hol D., Clapp C., Martínez de la Escalera G., HISTAMINE DIRECTLY STIMULATES GONADOTROPIN RELEASING HORMONE SECRETION FROM GT1-1 CELLS VIA H1 RECEPTORS COUPLED TO PHOSPHOINOSITIDE HYDROLYSIS., Endocrinology, January 1995; 137(0), 2967-2974

132. Torner L., Mejía S., López-Gómez F., Quintanar A., Martínez de la Escalera G., Clapp C., A 14 KDA PROLACTINLIKE FRAGMENT IS SECRETED FROM THE HYPOTHALAMONEUROHYPOPHYSEAL SYSTEM OF THE RAT., Endocrinology, January 1995; 136(0), 54-60

133. Clapp C., Torner L., Gutiérrez-Ospina G., Alcántara E., López-Gómez F., Nagano M., Kelly P., Mejía S., Morales M., Martínez de la Escalera, G., PROLACTIN GENE IS EXPRESSED IN THE HYPOTHALAMO-NEUROHYPOPHYSEAL SYSTEM AND THE PROTEIN IS PROCESSED INTO A 14 KDA FRAGMENT WITH 16K PROLACTIN-LIKE ACTIVITY., Proceedings Of The National Academy Of Sciences Of The United States Of America, January 1994; 91(0), 10384-10388

134. Hernández M.E., Clapp C., Martínez de la Escalera G., DOPAMINE-ESCAPE POTENTIATION OF PROLACTIN RELEASE INVOLVES THE ACTIVATION OF CALCIUM CHANNELS BY PROTEIN KINASES A AND C., Endocrine, January 1994; 2(0), 779-786

135. Martínez de la Escalera G., Choi A.L.H., Weiner. R. I., BIPHASIC GABAERGIC REGULATION OF GNRH SECRETION IN GT1 CELL LINES., Neuroendocrinology, January 1994; 59(0), 420-425

136. Martínez de la Escalera G., Weiner. R. I., ANALYSIS OF PULSATILITY IN IMMORTALIZED GNRH CELL LINES., Methods In Neuroscience, January 1994; 20(0), 3-12

137. Weiner. R. I., Martínez de la Escalera G., PULSATILE RELEASE OF GONADOTROPHIN RELEASING HORMONE (GNRH) IS AN INTRINSIC PROPERTY OF GT1 GNRH NEURONAL CELL LINES., Human Reproduction, January 1993; 8(0), 13-17

138. MARTINEZ DE LA ESCALERA G, CHOI ALH, WEINER RI., BETA-1 ADRENERGIC REGULATION OF THE GT1 GNRH NEURONAL CELL LINES STIMULATION OF GNRH RELEASE VIA RECEPTORS POSITIVELY COUPLED TO ADENYLATE CYCLASE., Endocrinology, January 1992; 131(0), 1397-1403

139. MARTINEZ DE LA ESCALERA G, CHOI ALH, WEINER RI., GENERATION AND SYNCHRONIZATION OF GNRH PULSES INTRINSIC PROPERTIES OF THE GT1-1 GNRH NEURONAL CELL LINE., Proceedings Of The National Academy Of Sciences Of The United States Of America, January 1992; 89(0), 1852-1855

140. MARTINEZ DE LA ESCALERA G, GALLO F, CHOI ALH, WEINER R., DOPAMINERGIC REGULATION OF THE GT1 GNRH NEURONAL CELL LINES STIMULATION OF GNRH RELEASE VIA D1RECEPTORS POSITIVELY COUPLED TO ADENYLATE CYCLASE., Endocrinology, January 1992; 131(0), 2965-2971

141. MARTINEZ DE LA ESCALERA G, WEINER RI., DISSOCIATION OF DOPAMINE FROM ITS RECEPTOR AS A SIGNAL IN THE PLEIOTROPIC HYPOTHALAMIC REGULATION OF PROLACTIN SECRETION., Endocrine Reviews, January 1992; 13(0), 241-255

142. MARTINEZ DE LA ESCALERA G, WEINER RI., HYPOTHALAMIC REGULATION OF MICROTUBULE-ASSOCIATED PROTEIN PHOSPHORYLATION IN LACTOTROPHS., Neuroendocrinology, January 1992; 55(0), 327-335

143. MENA F., HUMMELT G., AGUAYO D., CLAPP C., MARTINEZ DE LA ESCALERA G., MORALES M.T. , CHANGES IN MOLECULAR VARIANTS DURING IN VITRO TRANSFORMATION AND RELEASE OF PROLACTIN BY THE PITUITARY GLAND OF THE LACTATING RAT., Endocrinology, January 1992; 130(0), 3365-3377

144. WEINER RI, WETSEL, W, GOLDSMITH P, MARTINEZ DE LA ESCALERA G, WINDLE J, PADULA C, CHOI A, NEGROVILAR A, MELLON P., GONADOTROPIN RELEASING HORMONE CELL LINES., Frontiers In Neuroendocrinology, January 1992; 13(0), 95-119

145. MENA F., CLAPP C., AGUAYO D., MORALES M.T., MARTINEZ DE LA ESCALERA G., STIMULATORY AND INHIBITORY EFFECTS OF SUCKLING ON MILK SECRETION., Endocrine Regulations, January 1991; 25(0), 25-35

146. MARTINEZ DE LA ESCALERA G, WEINER RI., TRANSIENT DOPAMINE WITHDRAWAL DIFFERENTIALLY POTENTIATES TRHINDUCEDRELEASE OF PROLACTIN OF VARIOUS AGES., Neuroendocrinology, January 1990; 51(0), 694-699

147. MENA F., CLAPP C., AGUAYO D, MARTINEZ DE LA ESCALERA G., PROLACTIN AND PROPRANOLOL PREVENT THE SUCKLING INDUCED INHIBITION OF LACTATION IN RABBITS., Physiology And Behavior, January 1990; 48(2)(0), 311-315

148. MENA F., CLAPP C., MARTINEZ DE LA ESCALERA, G., AGE RELATED STIMULATORY AND INHIBITORY EFFECTS OF SUCKLING REGULATE LACTATION IN RABBITS., Physiology And Behavior, January 1990; 48(0), 307-310

149. Swearingen K.C., Martínez de la Escalera G., Weiner R.I, EPISODIC PROLACTIN RELEASE AFTER REMOVAL OF DOPAMINE INHIBITION IN VITRO., Bol. Estud. Med. Biol. Méx, January 1990; 38(0), 43-48

150. MARTINEZ DE LA ESCALERA G, PORTER BW, MARTIN TFJ, WEINER RI., DOPAMINE WITHDRAWAL AND ADDITION OF TRH STIMULATE MEMBRANE TRANSLOCATION OF PROTEIN KINASE C AND PHOSPHORYLATION OF AN ENDOGENOUS 80 KDA SUBSTRATE IN ENRICHED LACTOTROPHS., Endocrinology, January 1989; 125(0), 1168-1173

151. MARTINEZ DE LA ESCALERA G, SWEARINGEN KC, WEINER RI, SUPERFUSION AND STATIC CULTURE TECHNIQUES FOR THE MEASUREMENT OF RAPID CHANGES IN PROLACTIN SECRETION., Methods In Enzymology, January 1989; 168(0), 254-263

152. MENA F., CLAPP C., AGUAYO D., MARTINEZ DE LA ESCALERA G., DIFFERENTIAL EFFECTS OF THYROTROPIN RELEASING HORMONE ON IN VITRO RELEASE OF IN VIVO OR IN VITRO NEWLY SINTHETIZED AND MATURE PROLACTIN BY LACTATING RAT ADENOHYPOPHYSESFURTHER EVIDEN., Neuroendocrinology, January 1989; 49(0), 207-214

153. MENA F, CLAPP C. AGUAYO D, MORALES MT. GROSVENOR CE, MARTINEZ DE LA ESCALERA G., REGULATION OF PROLACTIN SECRETION BY DOPAMINE AND THYROTROPINRELEASING HORMONE IN LACTATING RAT ADENOHYPOPHYSESINFLUENCE OF INTRACELLULAR AGE OF THE HORMONE., Endocrinology, January 1989; 125(0), 1814-1820

154. MARTINEZ DE LA ESCALERA G, GUTHRIE J, WEINER RI., TRANSIENT REMOVAL OF DOPAMINE POTENTIATES THE STIMULATION OF PRL RELEASE BY TRH BUT NOT VIPSTIMULATION VIA CA2+PROTEIN KINASE C PATHWAY., Neuroendocrinology, January 1988; 47(0), 38-45

155. MARTINEZ DE LA ESCALERA G, WEINER RI, MECHANISMS BY WHICH THE TRANSIENT REMOVAL OF DOPAMINE REGULATION POTENTIATES THE PRL RELEASING ACTION OF TRH., Neuroendocrinology, January 1988; 47(0), 186-193

156. MARTINEZ DE LA ESCALERA G, WEINER RI., EFFECT OF DA WITHDRAWAL ON ACTIVATION OF ADENYLATE CYLASE AND PHOSPHOLIPASE C IN ENRICHED LACTOTROPHS., Endocrinology, January 1988; 123(0), 1682-1687

157. CLAPP C, MARTINEZ DE LA ESCALERA G, AGUAYO D, MENA F., REGULACION INTEGRATIVA DE LA LACTANCIA., Bol. Estud. Med. Biol. Méx, January 1987; 35(0), 63-107

158. MARTINEZ DE LA ESCALERA G, MARTIN TFJ, WEINER RI, PHOSOPHOINOSITIDE HYDROLYSIS IN RESPONSE TO THE WITHDRAWAL OF DOPAMINE INHIBITION IN ENRICHED LACTOTROPHS IN CULTURE., Neuroendocrinology, January 1987; 46(0), 545-548

159. MENA F., MARTINEZ DE LA ESCALERA G., CLAPP C., AGUAYO D., MORALES M.T., GROSVENOR C.E., INVESTIGATION INTO THE ROLE OF DOPAMINE AND LYSOSOMES IN THE IMPAIRMENT OF PROLACTIN TRANSFORMATION AND RELEASE IMPOSED BY LONG PERIODS OF NON-SUCKLING IN THE RAT., Acta Endocrinologica, January 1987; 114(0), 371-378

160. MARTINEZ DE LA ESCALERA G., CLAPP C., MORALES M.T., LORENSON M.Y., MENA F., REVERSAL BY THIOLS OF DOPAMINE-, STALK-MEDIAN EMINENCE- AND ZINC-INDUCED INHIBITION OF PROLACTIN TRANSFORMATION IN ADENOHYPOPHYSES OF LACTATING RATS., Endocrinology, January 1986; 118(0), 1803-1807

161. MENA F., CLAPP C., AGUAYO D., LORENSON M.Y., MARTINEZ DE LA ESCALERA G., THIOL REGULATION OF DEPLETION-TRANSFORMATION AND RELEASE OF PROLACTIN BY THE PITUITARY OF THE LACTATING RAT., Endocrinology, January 1986; 118(0), 1795-1802

162. CLAPP C, MARTINEZ DE LA ESCALERA G, MORALES MT, SHYR SW, GROSVENOR CE, MENA F., RELEASE OF CATECHOLAMINES FOLLOWS SUCKLING OR ELECTRICAL STIMULATION OF MAMMARY NERVE IN LACTATING RATS., Endocrinology, January 1985; 117(0), 2498-2503

163. MENA F, MARTINEZ DE LA ESCALERA G, CLAPP C, GROSVENOR C., IN VIVO AND IN VITRO SECRETION OF PROLACTIN BY LACTATING RAT ADENOHYPOPHYSES AS A FUNCTION OF INTRACELLULAR AGE., Journal Of Endocrinology, January 1984; 101(0), 27-32

164. MENA F., G. MARTINEZ DE LA ESCALERA, D. AGUAYO, C. CLAPP Y C.E. GROSVENOR., LATENCY AND DURATION OF THE EFFECTS OF BROMOCRIPTINE AND PROLACTIN ON MILK SECRETION IN LACTATING RABBITS., Journal Of Endocrinology, January 1982; 94(0), 389-395

165. MENA, F., MARTINEZ DE LA ESCALERA G., CLAPP C., AGUAYO D., FORRAY C., GROSVENOR C.E., A SOLUBILITY SHIFT OCCURS DURING DEPLETION TRANSFORMATION OF PROLACTIN WITHIN THE LACTATING RAT PITUITARY., Endocrinology, January 1982; 111(0), 1086-1091

166. MENA F, AGUAYO D, MARTINEZ DE LA ESCALERA G, GROSVENOR CE., EFFECT OF SHORT-TERM FOOD DEPRIVATION AND PROLACTIN UPON MILK YIELD IN THE LACTATING RABBIT., Physiology And Behavior, January 1981; 27(0), 529-532

167. MENA F, MARTINEZ DE LA ESCALERA G, CLAPP C, AGUAYO D, ANGUIANO G, GROSVENOR CE, EFFECT OF ACUTE INCREASE IN SUCKLING FREQUENCY UPON FOOD INTAKE AND MILK SECRETION IN THE RABBIT., Proceedings Of The Society For Experimental Biology And Medicine, January 1981; 168(0), 373-377

168. MENA F, PACHECO P, AGUAYO D, MARTINEZ DE LA ESCALERA G, GROSVENOR CE, REFLEX REGULATION OF AUTONOMIC INFLUENCES UPON THE OXYTOCIN INDUCED CONTRACTILE RESPONSE OF THE MAMMARY GLAND IN THE ANESTHETIZED RAT., Endocrinology, January 1979; 104(0), 751-757